SUBVERSIVE ACQUISITION LP announced today that InterCure Ltd., Israel’s leading cannabis company and SVX’s intended target for its “Qualifying Transaction” (the “Transaction”), has signed a Letter of Intent (“LOI”) with Cann Pharmaceutical Ltd. (“Cann”) to acquire Better Holdings (“Better”), a pioneering medical cannabis operator in Israel and Australia. Under the terms of the agreement, InterCure will acquire 100% of Cann’s shares, which includes Better’s operations in Israel and 50% of Cann Pharma’s shares, which owns the commercial rights to develop cannabis-based medical products. The Better acquisition expands InterCure’s global reach and accelerates international expansion strategy to major markets worldwide.
Published Ncv Newswire, New Cannabis Ventures, 04/05/2021 11:04:00